Research progress of dipeptidyl peptidase 4 inhibitors on healing of chronic diabetic foot ulcers
10.7507/1002-1892.201802034
- Author:
Yunyi GAO
1
Author Information
1. Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University
- Publication Type:Journal Article
- Keywords:
diabetic foot;
Dipeptidyl peptidase 4 inhibitor;
ulcer;
wound healing
- From:
Chinese Journal of Reparative and Reconstructive Surgery
2018;32(5):630-633
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To review the effect of dipeptidyl peptidase 4 (DPP-4) inhibitors on the wound healing and its mechanisms in chronic diabetic foot ulcers. Methods: The latest literature concerning DPP-4 inhibitors for chronic diabetic foot ulcers was extensively reviewed, as well as the potential benefit and mechanism of DPP-4 inhibitors on wound healing of diabetic foot ulcers was analyzed thoroughly. Results: DPP-4 inhibitors can accelerated the ulcer healing. The mechanisms probably include inhibiting the expression of the matrix metalloproteinase (MMP) and restoring the balance of the wound MMP and the tissue inhibitors of MMP; promoting recruitment of endothelial progenitor cells and augmenting angiogenesis; optimizing extracellular matrix construction and the immune response to persistent hypoxia in chronic diabetes wounds, and so on. At present, clinical researches show that DPP-4 inhibitors may be considered as an adjuvant treatment for chronic diabetic foot ulcers. Conclusion: DPP-4 inhibitors show promise in the local wound healing of chronic diabetic foot ulcers. However, more strictly designed, adequately powered, long-term follow-up, and high-quality randomized control trials are needed to further verify their efficacy and safety for chronic diabetic foot ulcers.
